FORNI, Flavio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 33.146
EU - Europa 17.573
AS - Asia 12.557
SA - Sud America 1.753
AF - Africa 246
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 25
Totale 65.339
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 32.866
GB - Regno Unito 6.566
CN - Cina 4.196
IT - Italia 4.169
SG - Singapore 3.709
SE - Svezia 1.990
HK - Hong Kong 1.887
BR - Brasile 1.417
DE - Germania 1.090
TR - Turchia 778
UA - Ucraina 768
RU - Federazione Russa 697
FI - Finlandia 567
VN - Vietnam 553
FR - Francia 447
KR - Corea 383
BG - Bulgaria 305
IN - India 241
NL - Olanda 166
RO - Romania 141
AR - Argentina 125
JP - Giappone 124
CA - Canada 123
IE - Irlanda 116
ID - Indonesia 101
MX - Messico 91
PL - Polonia 90
ZA - Sudafrica 89
BE - Belgio 84
ES - Italia 84
BD - Bangladesh 78
IQ - Iraq 57
CH - Svizzera 54
EC - Ecuador 54
PK - Pakistan 52
IR - Iran 49
MY - Malesia 45
TH - Thailandia 45
LT - Lituania 43
MA - Marocco 40
AE - Emirati Arabi Uniti 38
CO - Colombia 34
CL - Cile 33
IL - Israele 32
AU - Australia 31
EG - Egitto 30
UZ - Uzbekistan 30
CZ - Repubblica Ceca 29
PT - Portogallo 29
PE - Perù 26
VE - Venezuela 26
AT - Austria 22
DZ - Algeria 22
EU - Europa 20
GR - Grecia 19
PY - Paraguay 17
SA - Arabia Saudita 17
TW - Taiwan 17
JO - Giordania 16
MD - Moldavia 16
SN - Senegal 15
AZ - Azerbaigian 13
KZ - Kazakistan 13
TN - Tunisia 12
PH - Filippine 11
AL - Albania 10
BO - Bolivia 10
DK - Danimarca 10
NP - Nepal 10
UY - Uruguay 10
HU - Ungheria 9
JM - Giamaica 9
KE - Kenya 9
NO - Norvegia 9
NZ - Nuova Zelanda 8
DO - Repubblica Dominicana 7
LV - Lettonia 7
OM - Oman 7
AM - Armenia 6
BY - Bielorussia 6
CR - Costa Rica 6
EE - Estonia 6
LB - Libano 6
PA - Panama 6
RS - Serbia 6
ET - Etiopia 5
GT - Guatemala 5
HN - Honduras 5
KG - Kirghizistan 5
LK - Sri Lanka 5
NI - Nicaragua 5
TT - Trinidad e Tobago 5
YE - Yemen 5
BH - Bahrain 4
BZ - Belize 4
KH - Cambogia 4
LA - Repubblica Popolare Democratica del Laos 4
NG - Nigeria 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
Totale 65.273
Salva come PNG Salva come JPEG
Città #
Southend 5.220
Santa Clara 3.283
Ashburn 2.678
Fairfield 2.616
Singapore 2.328
Chandler 2.172
Woodbridge 1.903
Hong Kong 1.867
Jacksonville 1.617
Hefei 1.440
Houston 1.317
Dearborn 1.215
Wilmington 1.107
Seattle 1.068
Nyköping 1.060
Ann Arbor 1.049
Chicago 1.021
Cambridge 879
Beijing 749
London 722
Los Angeles 707
San Jose 594
Modena 485
Izmir 463
Salt Lake City 335
Princeton 324
Seoul 311
The Dalles 302
Sofia 300
New York 283
Council Bluffs 276
Helsinki 276
Eugene 275
Des Moines 242
Milan 240
San Diego 237
Dallas 212
Rome 191
Ho Chi Minh City 188
Buffalo 184
Redwood City 180
Moscow 179
Shanghai 152
Bremen 146
Tampa 142
Elk Grove Village 135
Hanoi 134
São Paulo 130
Munich 118
Fremont 104
Dublin 100
Tokyo 97
Columbus 96
Boardman 92
Bologna 89
Brussels 78
Falls Church 76
Lancaster 75
Naples 72
Guangzhou 70
Frankfurt am Main 69
Jakarta 65
Sterling 65
Phoenix 61
Miami 57
Parma 56
Norwalk 54
Brooklyn 52
Warsaw 50
Chennai 49
Como 49
Florence 49
Denver 48
Johannesburg 48
Nanjing 48
Atlanta 47
Dulles 47
Turin 46
Kunming 45
Lauterbourg 45
Stockholm 45
Detroit 41
Orem 41
Reggio Emilia 41
Napoli 39
Redondo Beach 38
Rio de Janeiro 38
Belo Horizonte 36
Bari 34
Montreal 34
Jinan 32
Toronto 32
Verona 32
Catania 31
Tulare 31
Kent 29
Palermo 29
San Mateo 29
Changsha 28
San Francisco 28
Totale 45.739
Salva come PNG Salva come JPEG
Nome #
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 518
A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol 485
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 465
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 450
Cristallinità ed equivalenza nel cloramfenicolo palmitato 437
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 433
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 412
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 409
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 395
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 395
Cationic liposomes for gene transfection 394
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 392
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 388
NUTRASCIENCE s.r.l. 388
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA) 385
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 384
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 381
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 376
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD 374
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 372
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 365
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 360
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 360
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 355
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 352
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 348
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 347
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 343
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 337
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 334
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 334
Distribution of drugs in polymers loaded by swelling 329
Polymeric nanoparticles for the drug delivery to the central nervous system 328
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 325
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 323
Diffusione di derivati dell\'acido benzoico attraverso membrane lipidiche in presenza di Tween 80 320
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 320
Nanoparticle transport across the blood brain barrier 318
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 318
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 317
Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog 317
Microwave-treated gelatin microspheres as drug delivery system 316
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 316
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 314
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 309
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 306
Protein corona and nanoparticles: How can we investigate on? 306
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 305
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives 303
Biodisponibilità e bioequivalenza in compresse commerciali di nitrofurantoina 302
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 301
The grinding of the polymorphic forms of chloramphenicol stearic ester in the presence of colloidal silica 300
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 298
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 298
Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles 296
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 295
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 295
A theoretical model for the calculation of the drug distribution profile in matrices of different shape to achieve the desired drug release kinetics 293
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 290
Nanoparticles engineered with rituximab and loaded with Nutlin-3 show promising therapeutic activity in B-leukemic xenografts. 289
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 287
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 286
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 285
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 284
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 283
Cannabinoid profiling of hemp seed oil by liquid chromatography coupled to high-resolution mass spectrometry 282
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 281
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 280
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabutol, the Butyl Homologue of Δ9-Tetrahydrocannabinol 279
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 278
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 278
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol 277
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 276
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 275
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 275
Colloidal systems for CNS drug delivery 274
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 273
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 268
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 266
Acidi colici nella preparazione di liposomi cationici per la transfezione in cellule HaCaT 265
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 263
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 263
Functionalization of liposomes: microscopical methods for preformulative screening 263
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 263
Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol 260
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 258
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 258
Chemical and spectroscopic characterization data of ‘cannabidibutol’, a novel cannabidiol butyl analog 258
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 257
Pitfalls in the analysis of phytocannabinoids in cannabis inflorescence 257
EFFECT OF MONTMORILLONITE ON DRUG RELEASE FROM POLYMERIC MATRICES 255
Activitè enzymatique de la pancréatine de formes pharmaceutiques: une nouvelle méthode d'évaluation 255
AN INTERPRETATIVE ANALYSIS OF THE EFFECT OF THE SURFACTANTS USED FOR THE PREPARATION OF POLYALKYLCYANOACRYLATE NANOPARTICLES ON THE RELEASE PROCESS 255
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 255
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 253
Papaverine hydrochloride release from ethyl cellulose-walled microcapsules 252
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 252
Solid state transitions and CAP availability in surface solid dispersions of chloramphenicol stearate polymorphs 250
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 250
Pseudomorfosi nel cloramfenicolo stearato e palmitato in relazione alla disponibilità 250
Totale 31.694
Salva come PNG Salva come JPEG
Categoria #
all - tutte 245.728
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 245.728
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.676 0 0 0 0 0 0 629 867 320 1.076 442 342
2021/20225.275 221 631 486 430 173 261 274 296 604 387 871 641
2022/20236.271 749 683 534 609 764 980 160 525 673 96 225 273
2023/20243.890 185 227 226 295 816 391 468 527 138 118 173 326
2024/202512.486 647 183 264 943 2.567 1.738 895 819 1.177 476 1.302 1.475
2025/202613.391 1.437 785 1.782 2.776 4.171 1.590 850 0 0 0 0 0
Totale 65.780